Skip to main content
See every side of every news story
Published • loading... • Updated

Stopping GLP-1 Drugs May Raise Heart Attack and Stroke Risk, Study Finds

Summary by WTVR
A recent study suggests the cardiovascular benefits of GLP-1 drugs may disappear quickly when treatment stops.

10 Articles

KPAXKPAX
+7 Reposted by 7 other sources
Center

Stopping GLP-1 drugs may raise heart attack and stroke risk, study finds

A recent study suggests the cardiovascular benefits of GLP-1 drugs may disappear quickly when treatment stops.

Stopping GLP-1 drugs can mean more than just the weight you've lost. A large study of more than 333,000 people with type 2 diabetes showed that after stopping treatment, protection against heart attack, stroke and death weakened. The analysis covered drugs, which include, among others, Ozempic, Wegovy, Mounjaro and Zepbound.

The cardiovascular benefits of GLP-1 drugs may weaken after discontinuation of treatment. A new study showed how the risks varied depending on the duration of the break.

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

ТСН.ua broke the news on Tuesday, September 22, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal